Texas SB 883: Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.

Status: Referred to Public Health (as of 2025-04-22)

State: Texas · Session: 89R · Bill: SB 883

Subjects: COVID-19 (SB9YM), Health Care Providers (I0387), Health--General (I0385), Health--Other Diseases & Medical Conditions (I0383), MEDICAL BOARD, TEXAS (V0644), MEDICINE & PRESCRIPTION DRUGS (S7338), PHYSICIANS (S1282), RIGHT TO TREAT ACT (P17XY)

Sponsors: Hall, Paxton, Kolkhorst, Sparks

View Texas SB 883 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.